Psychiatry and Neurology, Neurology · Aurora, CO
NPI
1790822054
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1635 Aurora Ct
Aurora, CO, 80045
Phone (720) 848-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
162 services
Medicare patients, 2024
119
Average age 61
Drug cost, 2024
$1.1M
1,498 prescriptions
Company payments, 2025
$84K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Enrique Alvarez III was code 99214 (office e&m - established), 91 times for 75 patients. In total Enrique Alvarez III billed 162 services in 4 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 91 | 75 | $69.53 | $6,328 |
| 99214 Office E&M - Established | Office | 32 | 29 | $84.18 | $2,694 |
| 99205 Office E&M - New | Facility | 19 | 19 | $135.49 | $2,574 |
| 99215 Office E&M - Established | Facility | 13 | 13 | $100.68 | $1,309 |
By year: 2022 $11K for 153 services; 2023 $9,110 for 141 services; 2024 $14K for 162 services.
Medicare prescription drug claims, 2024
In 2024, the drug Enrique Alvarez III prescribed most often to Medicare patients was Baclofen, with 184 prescriptions and refills. In total Enrique Alvarez III wrote 1,498 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 184 | 454 | 69 | $6,682 |
| Gabapentin Generic | 158 | 426 | 46 | $4,139 |
| Dalfampridine Er Dalfampridine | 155 | 339 | 39 | $56K |
| Amitriptyline Hcl Generic | 87 | 247 | 31 | $2,168 |
| Modafinil Generic | 59 | 125 | 17 | $23K |
| Oxcarbazepine Generic | 53 | 130 | 17 | $2,680 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 52 | 134 | 16 | $928 |
| Dimethyl Fumarate Generic | 40 | 49 | Under 11 | $111K |
| Tizanidine Hcl Generic | 40 | 97 | 14 | $987 |
| Carbamazepine Er Carbamazepine | 31 | 86 | 11 | $3,976 |
| Duloxetine Hcl Generic | 30 | 82 | 11 | $606 |
| Bupropion Xl Bupropion Hcl | 28 | 68 | Under 11 | $829 |
| Vumerity Diroximel Fumarate | 26 | 26 | Under 11 | $185K |
| Amantadine Amantadine Hcl | 26 | 61 | Under 11 | $1,113 |
| Fingolimod Fingolimod Hcl | 25 | 29 | Under 11 | $8,475 |
Brand drugs: 135 claims; generic drugs: 1,363 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Enrique Alvarez III $84K ($80K in general payments such as food, travel and fees and $4,410 for research) from 13 companies. The largest payer was Genzyme Corporation with $54K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 24 | $54K |
| Genentech USA, Inc. ROG.SW | 16 | $15K |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $4,841 |
| TG Therapeutics, Inc. TGTX | 21 | $4,821 |
| Novartis Pharmaceuticals Corporation NVS | 33 | $2,586 |
| Biogen, Inc. BIIB | 10 | $1,738 |
| Celgene Corporation BMY | 7 | $817 |
| EMD Serono, Inc. MRK.DE | 6 | $234 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $214 |
| Amgen Inc. AMGN | 4 | $128 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.